1-2 of 2
Chiara Paoli, MSc
Close
Sort by
Journal Articles

JAK2 V617F Complete Molecular Remission in Long-Term Follow-up of Patients with Polycythemia Vera and Essential Thrombocythemia Treated with Ruxolitinib

Lisa Pieri, MDPhD, Alessandro Pancrazzi, MSc, Annalisa Pacilli, PhD, Claudia Rabuzzi, BSci, Giada Rotunno, MSc, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Chiara Paoli, MSc, Tiziana Fanelli, MSc, Alberto Bosi, MD, Srdan Verstovsek, MD PhD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 3185.
https://doi.org/10.1182/blood.V124.21.3185.3185
Published: 2014
Journal Articles

A Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm: A Study from the AGIMM Group

Lisa Pieri, MDPhD, Chiara Paoli, MSc, Umberto Arena, MD, Fabio Marra, MD, Alessandro Castellani, MD, Stefano Colagrande, MD, Fabio Mori, MD, Arianna Masciulli, MSc, PhD, Silvia Betti, MD, Vittorio Rosti, MD, Ilaria Nichele, MD, Guido Finazzi, MD, Maria Luisa Ferrari, MD, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Rajmonda Fjerza, MD, Carmela Mannarelli, MSc, Tiziana Fanelli, MSc, Alberto Bosi, MD, Giuseppe Cimino, MD, Francesco Passamonti, MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Mario Cazzola, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 3192.
https://doi.org/10.1182/blood.V124.21.3192.3192
Published: 2014